http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3616693-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc2d182e6e8d98dd3faa3b517b6a11ea
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0034
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2018-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c98af64941bdb5dec41c44d5c46b9acd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16614fcceeaea12e5a3ca026e5519b7c
publicationDate 2020-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3616693-A1
titleOfInvention Therapy of high-risk human papillomavirus infections
abstract The present invention provides a pharmaceutical composition containing a selenite-containing compound and a pharmaceutically acceptable acid, selected from citric acid, acetic acid, malic acid, carbonic acid, sulfuric acid, nitric acid, hydrochloric acid, fruit acids and mixtures thereof. This composition is for use in the prevention or treatment of an infection of an internal reproductive organ of a female patient with at least one human papillomavirus (HPV) selected from HPV16, HPV18, HPV31, HPV33 and HPV58. The composition is applied intravaginally.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3875083-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021175877-A1
priorityDate 2018-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005048134-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013323328-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003180387-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012109685-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0185852-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03047604-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395777
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226490169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517055

Total number of triples: 45.